Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-08-14 09:00 am Purchase | 2026-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | Avoro Capital Advisors LLC | 13,823,383 9.640% | 2,305,942 (+20.02%) | Filing History |
| 2026-07-31 11:20 am Sale | 2026-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD PORTFOLIO MANAGEMENT LLC | 6,384,903 4.530% | -885,054 (-12.17%) | Filing History |
| 2026-07-27 4:25 pm Sale | 2026-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 14,232,545 10.100% | -2,871,539 (-16.79%) | Filing History |
| 2026-05-06 11:00 am Purchase | 2026-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | FMR LLC | 7,349,107 5.200% | 4,965,317 (+208.30%) | Filing History |
| 2026-04-29 4:44 pm Purchase | 2026-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD CAPITAL MANAGEMENT LLC | 7,081,293 5.050% | 7,081,293 (New Position) | Filing History |
| 2026-04-28 4:05 pm Purchase | 2026-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD PORTFOLIO MANAGEMENT LLC | 7,269,957 5.190% | 7,269,957 (New Position) | Filing History |
| 2026-04-24 4:11 pm Sale | 2026-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 17,104,084 12.200% | -3,219,137 (-15.84%) | Filing History |
| 2026-03-26 3:43 pm Sale | 2026-03-13 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 0 0.000% | -15,525,072 (Position Closed) | Filing History |
| 2026-01-21 12:30 pm Purchase | 2025-12-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 20,323,221 15.000% | 1,310,366 (+6.89%) | Filing History |
| 2025-08-15 5:28 pm Sale | 2025-08-13 | 13D | ARROWHEAD PHARMACEUTICALS INC ARWR | Sarepta Therapeutics, Inc. SRPT | 0 0.000% | -11,926,301 (Position Closed) | Filing History |
| 2025-08-14 07:07 am Sale | 2025-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | Avoro Capital Advisors LLC | 11,517,441 8.300% | -511,111 (-4.25%) | Filing History |
| 2025-08-11 07:01 am Sale | 2025-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORPORATION STT | 6,371,056 4.600% | -628,193 (-8.98%) | Filing History |
| 2025-07-29 11:20 am Purchase | 2025-06-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | VANGUARD GROUP INC | 15,525,072 11.240% | 3,121,022 (+25.16%) | Filing History |
| 2025-05-13 10:26 am Purchase | 2025-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORPORATION STT | 6,999,249 5.100% | 983,022 (+16.34%) | Filing History |
| 2025-04-23 8:14 pm Purchase | 2025-03-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | BlackRock Inc. BLK | 19,012,855 13.800% | 5,709,574 (+42.92%) | Filing History |
| 2025-02-14 5:23 pm Purchase | 2025-02-07 | 13D | ARROWHEAD PHARMACEUTICALS INC ARWR | Sarepta Therapeutics, Inc. SRPT | 11,926,301 9.500% | 11,926,301 (New Position) | Filing History |
| 2025-02-14 09:31 am Purchase | 2024-12-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | Avoro Capital Advisors LLC | 12,028,552 9.600% | 3,139,664 (+35.32%) | Filing History |
| 2025-02-05 06:41 am Sale | 2024-12-31 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORPORATION STT | 6,016,227 4.800% | -338,104 (-5.32%) | Filing History |
| 2024-11-14 09:38 am Purchase | 2024-09-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | Avoro Capital Advisors LLC | 8,888,888 7.200% | 8,888,888 (New Position) | Filing History |
| 2024-10-16 09:15 am Sale | 2024-09-30 | 13G | ARROWHEAD PHARMACEUTICALS INC ARWR | STATE STREET CORPORATION STT | 6,354,331 5.100% | -470,780 (-6.90%) | Filing History |